Saturday 17 October 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
1,006.92
8.28
+0.83%
Follow MCK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
20.13 | 22.40 | 23.49 | 23.94 |
+8 more quarters Free account |
P/S ratio |
0.22 | 0.27 | 0.25 | 0.25 | |
P/FCF ratio |
14.60 | 19.77 | 10.48 | 15.94 | |
P/Operating CF |
(407.68) | 31.27 | 82.03 | 39.58 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.24 | 0.28 | 0.28 | 0.27 | |
EV/EBITDA |
13.68 | 16.51 | 17.32 | 17.72 | |
EV/Operating CF |
14.49 | 18.62 | 10.47 | 15.24 | |
EV/FCF |
16.16 | 21.18 | 11.38 | 17.42 | |
Quick Ratio |
0.50 | 0.48 | 0.46 | 0.47 | |
Current Ratio |
0.89 | 0.85 | 0.88 | 0.88 | |
Net Debt/EBITDA |
6.36 | 3.26 | 4.82 | 5.55 | |
Debt/Assets |
16.74% | 14.11% | 13.85% | 15.28% | |
Debt/Equity |
(3.83) | (6.54) | (12.94) | (9.49) | |
Asset Turnover |
4.85 | 5.12 | 5.13 | 4.94 | |
Operating CF/Net income |
(0.36) | 2.03 | 1.04 | 2.18 | |
Capex/Depreciation |
(0.78) | (0.94) | (0.93) | (1.04) | |
Interest Coverage |
17.13 | 35.25 | 25.70 | 19.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.15% | 1.87% | 1.91% | 2.01% | |
Intangible Assets out of Total Assets |
0.17 | 0.19 | 0.18 | 0.18 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.33) | (0.25) | (0.25) | (0.27) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.97% | 4.47% | 4.26% | 4.18% | |
Free Cash Flow Yield |
6.85% | 5.06% | 9.54% | 6.27% | |
Revenue per Share |
887.78 | 779.09 | 861.67 | 831.85 | |
Operating CF per Share |
(1.85) | 27.68 | 10.00 | 19.52 | |
Capex per Share |
(1.28) | (1.50) | (1.42) | (1.58) | |
Free Cash Flow per Share |
(3.13) | 26.18 | 8.58 | 17.94 | |
Cash per Share |
43.50 | 32.16 | 24.02 | 32.29 | |
Shareholders Equity per Share |
(32.55) | (14.38) | (7.31) | (10.93) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(32.55) | (14.38) | (7.31) | (10.93) | |
Free Cash Flow |
(372.00) | 3,236.00 | 1,057.00 | 2,224.00 | |
Working Capital |
(7,519.00) | (9,807.00) | (8,434.00) | (8,144.00) | |
Capital Expenditures |
(152.00) | (185.00) | (175.00) | (196.00) | |
Net Current Asset Value |
(29,357.00) | (26,890.00) | (25,394.00) | (25,628.00) | |
EV/EBIT |
15.29 | 18.45 | 19.42 | 19.90 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
13.81 | 17.22 | 17.88 | 18.22 | |
| Other line items | |||||
Average Receivables |
29,237.00 | 26,814.00 | 27,022.00 | 26,778.00 | |
Average Payables |
60,796.00 | 57,651.50 | 55,186.00 | 57,127.50 | |
Average Inventory |
25,662.00 | 23,604.00 | 25,452.00 | 25,155.00 | |
Average Assets |
84,820.50 | 78,731.50 | 77,635.50 | 78,294.50 | |
Average Common Equity |
(2,726.00) | (1,735.50) | (1,802.50) | (1,998.50) |
Columns are period end dates